GoodRx Holdings (GDRX) Other Non-Current Liabilities (2019 - 2026)

GoodRx Holdings has reported Other Non-Current Liabilities for 8 years, with the latest figure at $8.7 million in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 25.79% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (up 25.79% YoY) and the FY2025 annual result came in at $8.7 million, up 29.4% from the prior year.
• Other Non-Current Liabilities eased to $8.7 million in Q1 2026 per GDRX's latest filing, from $8.7 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $9.6 million in Q2 2023 and troughed at $4.7 million in Q1 2022.
• A 5-year average of $7.7 million and a median of $7.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities fell 25.09% in 2022, then soared 70.04% in 2023.
• Over 5 years, Other Non-Current Liabilities stood at $7.6 million in 2022, then increased by 8.2% to $8.2 million in 2023, then decreased by 17.39% to $6.8 million in 2024, then advanced by 29.4% to $8.7 million in 2025, then slipped by 0.56% to $8.7 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $8.7 million, $8.7 million, and $7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.